Neogenomics (NEO) Asset Utilization Ratio (2011 - 2026)

Neogenomics (NEO) has 16 years of Asset Utilization Ratio data on file, last reported at 0.57 in Q2 2026.

• Quarterly Asset Utilization Ratio rose 23.41% year-over-year to 0.57 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.57 (up 23.41% YoY) and the FY2025 annual result came in at 0.49, up 21.91% from the prior year.
• Asset Utilization Ratio climbed to 0.57 in Q2 2026, from 0.55 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.57 in Q2 2026 to a low of 0.26 in Q1 2022.
• A 5-year average of 0.39 and a median of 0.38 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio sank 55.9% — and 2026, when it soared 32.8%.
• Tracing NEO's Asset Utilization Ratio over 5 years: stood at 0.29 in 2022, then rose by 20.77% to 0.35 in 2023, then gained by 14.38% to 0.4 in 2024, then jumped by 32.03% to 0.53 in 2025, then grew by 6.76% to 0.57 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.57 (Q2 2026), 0.55 (Q1 2026), and 0.53 (Q4 2025), per Business Quant data.